Gujarat Terce Laboratories Ltd

NSE: GUJTERC · BSE: 524314 · Pharmaceuticals & Biotechnology · 3 announcements

Share price: ₹39.29
Market cap: ₹29.15 Cr
Revenue (annual): ₹47.47 Cr
Net profit (annual): ₹2.20 Cr
P/E (TTM): 14.0×Sector 50.4×
Promoter holding: 40.03%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Earnings Call 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements

7 Aug 2026 16:45 IST BSE

Financial Results

Gujarat Terce Laboratories Q1 FY27 Results: Net Loss of ₹0.2 Cr

Gujarat Terce Laboratories Ltd reported revenue from operations of ₹9 Cr (-17.4% YoY) and a net loss of ₹0.2 Cr for Q1 FY27.

Key figure: Net loss ₹0.2 Cr

Open full results → Read the filing ↗

3 Jun 2026 16:41 IST BSE

Earnings Call

Gujarat Terce Laboratories Earnings Call: Key Takeaways

Gujarat Terce reports a challenging Q4 FY26 with an 8% revenue decline but a return to profitability (PAT 10.1L vs loss). Strategy focuses on brand equity and field productivity.

Open call summary → Read the filing ↗

29 May 2026 22:24 IST BSE

Financial Results

Gujarat Terce Laboratories Q4 FY26 Results: Turns Profitable, Net Profit ₹0.1 Cr

Gujarat Terce Laboratories Ltd reported revenue from operations of ₹11.4 Cr (-7.3% YoY) and net profit of ₹0.1 Cr for Q4 FY26.

Key figure: Net profit ₹0.1 Cr

Open full results → Read the filing ↗